CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00075192
First received: January 5, 2004
Last updated: June 5, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2006
  Estimated Primary Completion Date: No date given